HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800.

Slides:

Advertisements

Similar presentations

Rat Dissection RATS The following slides are intended to help you with dissection of the rat and then to review for the lab practical that will follow.

Advertisements

Preventing Cancer with Healthy Life Styles Li-Fen L. Chang, M.D., Ph.D. Radiation Oncology SOMC Cancer Center.

Rat Dissection MUSCLES Source #5 Rat Dissection MUSCLES Source #5.

National Institute of Oncology Rabat-Morocco. National Institute of Oncology I.N.O. Rabat, Morocco : New Cases.

An Introduction to Cancer Biology Geoff Mitchell April 24, 2007.

BMP receptor1a Amit Patel Estimated US Cancer Deaths* ONS=Other nervous system. Source: American Cancer Society, Men 295,280 Women 275,000.

Cancer Dr. Raid Jastania. Cancer In the US: 1.3 million new cancer cases in 2002 >500,000 death of cancer Increase cancer death in men due to lung cancer.

Risk factors of non-smoking lung cancer Po-Yin Chang.

Tuesday, June 23, Today’s discussion General cancer statistics Cancer in Canada PEI Statistics at a glance Impact.

Dietary intakes of calcium and vitamin D and risk of colorectal cancer in women Jennifer Lin, PhD Division of Preventive Medicine Brigham and Women’s Hospital.

Multi-dimensional Genomic Profiling of Acute Leukemias Characterized by MLL gene rearrangements Eunice S. Wang MD (Medicine) and Norma J. Nowak PhD (Cancer.

ONCOLOGY Epidemiology. 1LungBreastLung1,037,000 2StomachColon/rectumStomach798,000 3Colon/rectumCervix uteriBreast796,000 4ProstateStomachColon/rectum783,000.

* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.

Advances in Nuclear Medicine and its Impact on Diagnosis and Management of GI Cancers Medhat Osman, MD PhD Philip Alderson, MD.

Cancer Epidemiology and Cancer Prevention Epidemiology 242 December 2, 2009.

Epidemiology of Oral Cancer Module 1:. Epidemiology of Cancer, U.S.

Cancer as a genetic chapter 23 select topics and lecture notes.

* For those free of cancer at beginning of age interval. Source: DevCan: Probability of Developing or Dying of Cancer Software, Version Statistical.

Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.

Understanding Cancer. Different Kinds of Cancer Lung Breast (women) Colon Bladder Prostate (men) Some common sarcomas: Fat Bone Muscle Lymphomas: Lymph.

United States Cancer Registries FDA Meeting of Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee October 30, 2003 Phyllis A. Wingo,

Recurrence of Malignancy after Transplantation ANZDATA - Australian and New Zealand Dialysis and Transplant Registry NSW Cancer Council.

Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.

Human Biology Sylvia S. Mader Michael Windelspecht

US Cancer Burden Epi 242 Cancer Epidemiology Binh Goldstein, Ph.D. October 7, 2009.

1 Cancer Etiology Dan Aderka MD Molecular mechanisms Environment Cancer cells.

Regulating the Cell Cycle Biology 392 Chapter 10-3.

Breast Cancer: Treatment or Not? HFE 742 Cathy Simmons November 10, 2005.

RT-PCR:PRKWNK1, WNK1, T39 T40 (232 bp) Bedingungen: 2% TBE 90 V 1h 40 min 9 µl PCR-Probe 2 µl Ladepuffer _Gewebe_1_A1_T39T40_calb M

Prostate Cancer Treatment: What’s Best For You?

WE WILL ALL DIE OF CANCER If something else doesn’t kill us first HYPOTHESIS:

RT-PCR: PRKWNK1,WNK1, T39 T40 (232 bp), Reamplifikation _Reampli_Gewebe_1_A1_T39T40_calb Bedingungen: 2% TBE 90V 1h 40min 9 µ Reampli-Probe 2 µl.

RT-PCR: PC326, T146 T147 (240 bp) _Gewebe_1_B1_T146T147_calb Bedingungen: 2% TBE 90V 1h 40min 9 µl PCR-Probe 2 µl LB M

Slides last updated: October Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM. GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality.

Cancer Affecting Puerto Rico Norman Maldonado MD April 2015.

RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Cancer.

Regulating the Cell Cycle

Role of the Surgeon in Cancer Management A. Responsible for the initial diagnosis and management of solid tumors. B. Responsible for the Definitive Surgical.

Cancer as a genetic chapter 21 pp & lecture notes.

EEOICPA Compensation Results (through March 2004) Russ Henshaw, MS Epidemiologist NIOSH/Office of Compensation Analysis & Support Cincinnati, OH.

Tools to Access the Latest Cancer Statistics Paul Miller Washington Reporting Fellowships program presentation April 15, 2013.

Comprehensive Cancer Alliance for Idaho Idaho’s Hit List CCAI General Meeting November 14, 2007 Chris Johnson, MPH Cancer Data Registry of Idaho.

The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Fall, 2005.

The Genetic Component of a Common Disease The Paradigm of Cancer Genetics John Quillin, PhD, MPH, MS Virginia Commonwealth University Summer, 2006.

Chapter 10 - Mitosis and Cytokinesis Warm Up – 11/20 List the differences between Asexual and Sexual Reproduction. Name two types of asexual reproduction.

RT-PCR: BCLG, T84 T85 (487bp) _Gewebe_1_A2_T84T85_calb Bedingungen: 2% TBE 90V 1h 45min 9 µl PCR-Produkt 2 µl LB M

Homework #3 is due 11/19 Bonus #2 is posted. Cancer: is the loss of control over cell division. Tumors are normal cells that are dividing inappropriately.

Slides last updated: March Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN.

Cell Cycle Regulation and Cancer. 3 Checkpoints Control the cell cycle (inspection points) Make sure the cell is ready to move into the next phase. Mitosis.

Cancer Liaison Physician Report Sibley Memorial Hospital Cancer Committee Meeting September 14, 2015.

Riva L. Rahl, M.D. Cooper Clinic Preventive Medicine Physician Medical Director, Cooper Wellness Program Cancer: Beating the Odds.

Cancer: causes abnormal and uncontrolled cell growth to occur within body Because cancer cells continue to grow and divide, they are different from normal.

Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,

Quality of Life after Prostate Cancer Treatment: Trajectories of Recovery using Piecewise Latent Growth Curve Analyses Michael A. Diefenbach, Ph.D., Icahn.

Qualified Patient Criteria Combinations (Female and Male) Personal History of (any one of the below): Breast or Ovarian cancer (any age) Prostate or Pancreatic.

Survival in most affluent

US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death

CANCER Carbon Co. Luzerne Schuylkill Pennsylvania TABLE 1. Distribution of Cancers by Type for Tamaqua Study Counties and Pennsylvania Based on

5 Prevalence ZEINAB This module presents statistics from Chapter 5: Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.

Non-Communicable Diseases Lesson 7

5 Prevalence Ontario Cancer Statistics 2016 Chapter 5: Prevalence.

The 20 Most Common Cancers in 2012

Citation: Cancer Care Ontario

・FFPE tumor tissue array (Biochain, cat. T )

Trends of mortality rates in the USA between 1930 and 2000 in males according to cancer site. –––––: stomach; ·······: prostate; –– –– ––: colon and rectum;

Presentation transcript:

HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800

Brain-CNS, Benign/Borderline – 95 (2.64%) Brain, Malignant – 135 (3.75) Oral Cavity & Pharynx – 144 (4.00%) Esophagus – 35 (0.97%) Lung & Bronchus – 219 (6.09%) Stomach – 50(1.39%) Pancreas – 232 (6.45%) Colon & Rectum – 138 (3.84%) Kidney & Renal Pelvis – 155 (4.31%) Urinary Bladder – 163 (4.53%) Prostate – 1124 (31.26%) Non-Hodgkin Lymphoma – 100 (2.78%) Melanoma of the Skin – 193 (5.37%) Leukemia – 147 (4.09%) All other sites – 666 (18.52%) Brain-CNS, Benign/Borderline – 152 (5.43%) Brain, Malignant – 111 (3.96) Oral Cavity & Pharynx – 67 (2.39) Thyroid – 282 (10.07%) Stomach – 28 (1.00%) Lung & Bronchus – 226 (8.07%) Breast – 555 (19.82%) Pancreas – 196 (7.00%) Kidney & Renal Pelvis – 86 (3.07%) Corpus Uteri – 88 (3.14%) Colon & Rectum – 106 (3.79%) Non-Hodgkin Lymphoma – 94 (3.36%) Melanoma of the skin – 159 (5.68%) Leukemia – 99 (3.54%) All other sites – 551 (19.67%) Males 3596 Females 2800

HEAD/NECK OF THE SKIN ANALYTIC vs. NON-ANALYTIC by YEAR N = 1800